Skip Navigation


Mol. Hum. Reprod. Advance Access originally published online on November 7, 2008
Molecular Human Reproduction 2008 14(12):673-678; doi:10.1093/molehr/gan064
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
14/12/673    most recent
gan064v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Li, Q.
Right arrow Articles by Matzuk, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Q.
Right arrow Articles by Matzuk, M. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

This article appears in the following Molecular Human Reproduction issue: Special Issue: Emerging Technologies for the Assessment of Gametes and Embryos - The OMICS [View the issue table of contents]

Revisiting oocyte–somatic cell interactions: in search of novel intrafollicular predictors and regulators of oocyte developmental competence

Qinglei Li1, Laurie J. McKenzie1,2 and Martin M. Matzuk1,3,4,5

1Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA 2Houston IVF, Memorial Hermann Memorial City Hospital, Houston, TX 77024, USA 3Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA 4Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA

5 Correspondence address: Tel: +1 713-798-6451; Fax: +1 713-798-5833; E-mail: mmatzuk{at}bcm.tmc.edu

Prediction and improvement of oocyte competence are two critical issues in assisted reproductive technology to improve infertility therapy. The lack of reliable and objective predictors of oocyte developmental competence for oocyte/embryo selection during in vitro fertilization hampers the effectiveness of this technology. Likewise, the low pregnancy rate resulting from in vitro maturation of human oocytes represents a major obstacle for its clinical application. Oocyte competence is progressively acquired during follicular development, and the oocyte plays a dominant role in regulating granulosa cell functions and maintaining the microenvironment appropriate for the development of its competence. Hence, granulosa cell functions are reflective of oocyte competence, and molecular markers of granulosa cells are potentially reliable predictors of oocyte quality. With the advent of the functional genomics era, the transcriptome of granulosa cells has been extensively characterized. Experimental data supporting granulosa cell markers as predictors of oocyte competence are now emerging in both animal models and humans. Future efforts should focus on integrating granulosa cell genetic markers as parameters for oocyte/embryo selection. Moreover, novel in vitro evidence highlights the effectiveness of exogenous oocyte-secreted factors in promoting oocyte developmental competence in animal models. The challenge in evaluating the effect of oocyte-secreted factors on oocyte quality in a clinical setting is to standardize the various preparations of these recombinant proteins and decipher their complex interactions/cooperativity within the germline-somatic cell regulatory loop.

Submitted on September 3, 2008; resubmitted on October 27, 2008; accepted on October 29, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
Q. Li, S. Rajanahally, M. A. Edson, and M. M. Matzuk
Stable expression and characterization of N-terminal tagged recombinant human bone morphogenetic protein 15
Mol. Hum. Reprod., December 1, 2009; 15(12): 779 - 788.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Duffin, R.A.L. Bayne, A.J. Childs, C. Collins, and R.A. Anderson
The forkhead transcription factor FOXL2 is expressed in somatic cells of the human ovary prior to follicle formation
Mol. Hum. Reprod., December 1, 2009; 15(12): 771 - 777.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. G. Hillier
Paracrine support of ovarian stimulation
Mol. Hum. Reprod., December 1, 2009; 15(12): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
R A Anderson, R Sciorio, H Kinnell, R A L Bayne, K J Thong, P A de Sousa, and S Pickering
Cumulus gene expression as a predictor of human oocyte fertilisation, embryo development and competence to establish a pregnancy
Reproduction, October 1, 2009; 138(4): 629 - 637.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.